USP Disintegration Apparatus as a Potential Tool for Evaluating Drug Release from Controlled-Release Dosage Forms

Official compendia lack in vitro dissolution guidelines for simulated fed conditions. The goal of this project was to
compare disintegration times and drug release characteristics for Polygel CR tablets using USP dissolution Apparatus 1
and the USP disintegration apparatus. Calcium tablets plus vitamin D with different deaggregation properties were also
used to study the food-weight effect on tablet disintegration. A USP disk, either flat or on its side, was placed on a tablet
contained inside the USP disintegration apparatus to simulate the dosage form being in total contact with food after a
heavy meal or in partial contact with food after a light meal, respectively. Drug release profiles for Polygel CR tablets in a
simulated fasted state were not remarkably different whether the USP disintegration apparatus or USP dissolution
Apparatus 1 was used (66.3 ± 2.1% versus 55.3 ± 1.3% in 6 h). Drug release, however, was observed to be higher in the
simulated fed state when the USP disintegration apparatus with a disk was used (88.9 ± 5.9% versus 47.5 ± 0.8% in 6 h,
p < 0.05). The data generated using calcium tablets plus vitamin D also suggest that food weight does not significantly
accelerate the disintegration of tablets designed with rapid disintegration properties. However, the presence of a meal in
the stomach may speed up the disintegration of slower disintegrating tablets.